newdrugapprovals.org
FDA approves treatment Poteligeo (mogamulizumab-kpkc) for two rare types of non-Hodgkin lymphoma
FDA approves treatment for two rare types of non-Hodgkin lymphoma The U.S. Food and Drug Administration today approved Poteligeo (mogamulizumab-kpkc) injection for intravenous use for the tr…